Published in J Osteoporos on October 04, 2012
Pycnogenol(®) treatment inhibits bone mineral density loss and trabecular deterioration in ovariectomized rats. Int J Clin Exp Med (2015) 0.75
Osteoporosis prevention, diagnosis, and therapy. JAMA (2001) 12.60
Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest (2006) 3.45
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst (2009) 2.34
Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab (2003) 2.27
Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun (2001) 2.18
The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone (1999) 2.16
Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging (2007) 2.09
Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest (2003) 1.84
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology (2004) 1.66
Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta (2005) 1.58
Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab (2002) 1.57
Trabecular bone pattern factor--a new parameter for simple quantification of bone microarchitecture. Bone (1992) 1.53
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest (1999) 1.50
Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem (2000) 1.47
Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov (2002) 1.46
Vitamin C supplement use and bone mineral density in postmenopausal women. J Bone Miner Res (2001) 1.31
Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int (2007) 1.30
Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int (2007) 1.20
Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. J Bone Miner Res (2001) 1.19
Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res (2000) 1.17
Green tea and bone metabolism. Nutr Res (2009) 1.12
Profiles of antioxidants in human plasma. Free Radic Biol Med (2001) 1.02
Anticarcinogenic effects of selenium. Cell Mol Life Sci (2000) 0.96
Bone mass assessment in rats by dual energy X-ray absorptiometry. Br J Radiol (1998) 0.95
Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther (2009) 0.95
Serum carotenoid concentrations in postmenopausal women from the United States with and without osteoporosis. Int J Vitam Nutr Res (2008) 0.92
Osteoporosis prevention and therapy: preserving and building strength through bone quality. Osteoporos Int (2006) 0.91
Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C. World J Gastroenterol (2010) 0.88
The role of vitamin E in reversing bone loss. Aging Clin Exp Res (2008) 0.81
Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model. Calcif Tissue Int (2008) 0.81
Oxygen free radical and antioxidant defense mechanism in cancer. Front Biosci (2004) 0.79
Effects of LY-117018 HCl on bone remodeling and mineral density in the oophorectomized rat. Am J Obstet Gynecol (1998) 0.77
Risk factors for prediction of inadequate response to antiresorptives. J Bone Miner Res (2012) 1.61
Association between phosphate removal and markers of bone turnover in haemodialysis patients. Nephrol Dial Transplant (2006) 1.45
Characterization of a new experimental model of osteoporosis in rabbits. J Bone Miner Metab (2008) 1.11
miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis. Bone (2012) 0.97
Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease. Aging Clin Exp Res (2010) 0.88
Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study. Aging Clin Exp Res (2009) 0.85
Relationship between vitamin D deficiency, bone remodelling and iron status in iron-deficient young women consuming an iron-fortified food. Eur J Nutr (2012) 0.85
Bone remodelling is reduced by recovery from iron-deficiency anaemia in premenopausal women. J Physiol Biochem (2013) 0.85
Low iron status as a factor of increased bone resorption and effects of an iron and vitamin D-fortified skimmed milk on bone remodelling in young Spanish women. Eur J Nutr (2013) 0.84
Effects of PTH (1-84) on bone quality in a validated model of osteoporosis due to androgenic deprivation. Aging Male (2013) 0.79
Pharmacological treatment of osteoporosis for people over 70. Aging Clin Exp Res (2007) 0.79
Bone remodelling is not affected by consumption of a sodium-rich carbonated mineral water in healthy postmenopausal women. Br J Nutr (2005) 0.79
Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis. BMC Vet Res (2014) 0.78
Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis. Clin Interv Aging (2008) 0.78
Impact of estrogens on atherosclerosis and bone in the apolipoprotein E-deficient mouse model. Menopause (2015) 0.78
Prevalence of vertebral fracture in postmenopausal women with lumbar osteopenia using MorphoXpress® (OSTEOXPRESS Study). Aging Clin Exp Res (2010) 0.77
The deleterious effect of bariatric surgery on cortical and trabecular bone density in the femurs of non-obese, type 2 diabetic Goto-Kakizaki rats. Obes Surg (2012) 0.77
Comparative effects of bicalutamide (Casodex) versus orchidectomy on bone mineral density, bone remodelling, and bone biomechanics in healthy rats. Urol Int (2005) 0.77
Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice. J Bone Miner Metab (2014) 0.77
Changes in bone density and bone markers in rhythmic gymnasts and ballet dancers: implications for puberty and leptin levels. Eur J Endocrinol (2004) 0.77
Downregulation of the inflammatory response by CORM-3 results in protective effects in a model of postmenopausal arthritis. Calcif Tissue Int (2012) 0.77
Up-regulation of the inflammatory response by ovariectomy in collagen-induced arthritis. effects of tin protoporphyrin IX. Inflammation (2011) 0.76
Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells. J Rheumatol (2004) 0.75
[Diagnosis and treatment of osteoporosis in persons aged more than 75 years]. Rev Esp Geriatr Gerontol (2010) 0.75